Bronchiectasis in adult patients: An expression of heterozygosity for CFTR gene mutations?

Clinical Genetics

Volumn 65, Issue 6, 2004, Pages 490-495

  Casals, Teresa ^a   De Gracia, J ^b   Gallego, M ^c   Dorca, J ^d   Rodriguez Sanchon B ^d   Ramos, M D ^a   Gimenez J ^a   Cistero Bahima A ^d   Olveira, C ^e   Estivill, X ^a,f  

^a HOSPITAL DURAN I REYNALS   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL DE SABADELL   (Spain)

^d INSTITUT UNIVERSITARI DEXEUS   (Spain)

^e HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^f CENTRE FOR GENOMIC REGULATION CRG   (Spain)

Author keywords

Adult bronchiectasis; CF related diseases; CFTR mutations; Cystic fibrosis

Indexed keywords

GUANINE; METHIONINE; THYMIDINE; TRANSMEMBRANE CONDUCTANCE REGULATOR; VALINE;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BRONCHIECTASIS; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC RISK; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STATISTICAL SIGNIFICANCE;

ADULT; BRONCHIECTASIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; GENOTYPE; HETEROZYGOTE; HUMANS; MALE; MUTATION; SPUTUM;

STAPHYLOCOCCUS AUREUS;

EID: 2942731805     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0009-9163.2004.00265.x     Document Type: Article

References (28)

1. Cole P, Flower CDR, Lavender JP. Clinical and imaging aspects of bronchiectasis. In: Pulmonary radiology: The Fleischner Society (Potchen EJ, Grainger RG, Greene R, eds). Philadelphia, PA: W. B. Saunders, 1993: 242-258.
2. Welsh MJ, Ramsey BW, Accurso F et al. Cystic fibrosis. In: The Metabolic and Molecular Bases of Inherited Disease, 8th edn. (Sly WS, Valle D, eds). New York: McGraw-Hill Inc., 2001: 5121-5188.
3. Kerem B, Rommens JM, Buchanan JA et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989: 245: 1073-1080.
4. Cystic Fibrosis Mutation Data Base. (available from: http://www.genet.sickkids.on.ca).
5. Weiner-Miller P, Hamosh A, Macek M et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet 1996: 59: 45-51.
6. Marchand E, Verellen-Dumoulin C, Mairesse M et al. Frequency of cystic fibrosis transmembrane conductance regulator gene mutations and 5T allele in patients with allergic bronchopulmonary aspergillosis. Chest 2001: 119: 762-767.
7. Pignatti PF, Bombieri C, Marigo C et al. Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasis. Hum Mol Genet 1995: 4: 635-639.
8. Girodon E, Cazeneuve C, Lebargy F et al. CFTR gene mutations in adults with disseminated bronchiectasis. Eur J Hum Genet 1997: 5: 149-155.
9. Bombieri C, Benetazzo M, Saccomani A et al. Complete mutational screening of the CFTR gene in 120 patients with pulmonary disease. Hum Genet 1998: 103: 718-722.
10. Pasteur MC, Helliwell SM, Houghton SJ et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000: 162: 1277-1284.
11. Tzetis M, Efthymiadou A, Strofalis S et al. CFTR gene mutations - including three novel nucleotide substitutions - and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease. Hum Genet 2001: 108: 216-221.
12. Lázaro C, de Cid R, Sunyer J et al. Missense mutations in the cystic fibrosis gene in adult patients with asthma. Hum Mutat 1999: 14: 510-519.
13. Cuppens H, Lin W, Jaspers M et al. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (TG)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. Hum Mol Genet 1998: 101: 487-496.
14. Niksic M, Romano M, Buratti E et al. Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9. Hum Mol Genet 1999: 13: 2339-2349.
15. Chillón M, Casals T, Mercier B et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 1995: 332: 1475-1480.
16. Naidich DP, McCauley DI, Khouri NF et al. Computed tomography of bronchiectasis. J Comput Assist Tomogr 1982: 6: 437-444.
17. Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine and iontophoresis. Pediatrics 1959: 23: 549-563.
18. Rosenberg M, Patterson R, Mintzer R et al. Clinical and immunological criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 1977: 85: 405-414.
19. Casals T, Ramos MD, Gimenez J et al. High heterogeneity for cystic fibrosis in spanish families: 75 mutations account for 90% of chromosomes. Hum Genet 1997: 101: 365-370.
20. Costes B, Fanen P, Goossens M et al. A rapid, efficient and sensitive assay for simultaneous detection of multiple cystic fibrosis mutations. Hum Mutat 1993: 2: 185-191.
21. Cuppens H, Teng H, Raeymaekers P et al. CFTR haplotype backgrounds on normal and mutant CFTR genes. Hum Mol Genet 1994: 4: 607-614.
22. Dörk T, Dworniczak B, Aulehla-Scholz C et al. Distinct spectrum of CFTR-gene mutations in congenital absence of vas deferens. Hum Genet 1997: 100: 365-377.
23. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cysic Fibrosis Foundation Consensus Panel. J Pediatr 1998: 132: 589-595.
24. Dohle GR, Halley DJJ, Van Hemel JO et al. Genetic risk factors in infertile men with severe oligozoospermia and azoospermia. Hum Reprod 2002: 17: 13-16.
25. Chu CS, Trapnell BC, Curristin S et al. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet 1993: 3: 151-156.
26. Casals T, Bassas LI, Egozcue S et al. Heterogeneity for mutations in the CFTR gene and clinical correlations in patients with congenital absence of the vas deferens. Hum Reprod 2000: 15: 1476-1483.
27. Wang X, Moylan B, Leopold DA et al. Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. JAMA 2000: 284: 1814-1819.
28. Pagani F, Stuani C, Tzetis M et al. New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12. Hum Mol Genet 2003: 12: 1111-1120.